Krutika Kuppalli, MD
Krutika Kuppalli, MD, FIDSA is part of the Mpox (Monkeypox) core Technical Team in the Health Emergencies Program at the World Health Organization. She completed her Internal Medicine residency and Infectious Diseases fellowship at Emory University, a Post-Doctoral Fellowship in Global Public Health at the University of California, San Diego and was an Emerging Leader in Biosecurity Fellowship at the Johns Hopkins Center for Health Security in 2021. Dr. Kuppalli currently serves as the Chair of the Infectious Diseases Society of America (IDSA) Global Health Committee.
Dr. Kuppalli was previously awarded the NIH Fogarty International Clinical Research Fellowship and conducted research in Southern India to understand barriers to care and how emerging infections impacted the disease course in persons living with HIV/AIDS. She was the medical director of a large Ebola Treatment Unit in Sierra Leone during the 2014 West Africa Ebola outbreak, has helped lead the development and implementation of pandemic response preparedness activities in resource limited settings, and has consulted on the development of therapeutics for emerging pathogens. Her clinical and research interests focus on health systems strengthening in resource limited settings, research and clinical care for emerging infections, outbreak preparedness and response, and policy. She has worked in numerous countries including Ethiopia, India, Sierra Leone, Uganda, and Haiti.
During the COVID-19 pandemic Dr. Kuppalli served as a consultant for the San Francisco Department of Health and helped plan and operationalize a field hospital. She served as an expert witness to the U.S. Congress, Financial Services Committee Task Force on Artificial Intelligence (AI) about how digital technologies may be leveraged for exposure notification and contact tracing to improve the pandemic response. She also collaborated with the Brennan Center for Justice to develop guidelines to inform “Healthy in-person Voting” in advance of the 2020 U.S. election and testified before the U.S. House Select Subcommittee regarding these recommendations. Prior to her position at WHO, she was the medical lead for COVID-19 vaccine rollout at the Medical University of South Carolina (MUSC) and helped coordinate vaccine education events to help engage and educate staff and patients, particularly those in underserved locations to increase vaccine uptake.
In August 2021, Dr. Kuppalli joined WHO Headquarters in Geneva, Switzerland as part of the COVID-19 pandemic response where she was an integral part of the global incident management team. Her responsibilities included serving as a member of the secretariat for the Scientific Advisory Group on the Origins of Novel Pathogens (SAGO), contributing to the clinical characterization and management working group for COVID-19, participating in the COVID-19 therapeutics steering committee, and serving as the technical focal point for the post COVID-19 condition (Long COVID) steering committee. Additionally, she was actively involved as a member of the Ebola Virus Disease therapeutics steering committee.
Dr Kuppalli has been a core member of the global WHO incident management team since the beginning of the multi-country mpox outbreak in May 2022. In this capacity, she collaborated on the development of various technical documents, including normative guidance materials. She has provided support for proceedings with the IHR Emergency Committee and participated in two high-level missions to Nigeria and the Central African Republic. Currently, she is working to develop the global mpox partnership and supporting the strategic framework aimed at controlling and eliminating human-to-human transmission of mpox.
Financial relationships
-
Type of financial relationship:There are no financial relationships to disclose.Date added:01/08/2024Date updated:01/07/2024
**Disclaimer**
This Continuing Medical Education (CME) Learning Management System, Ethos, includes individuals designated as 'faculty' for CME purposes. Please note that the term 'faculty' refers solely to their role as a contributor/planner within a CME activity and does not imply any formal affiliation with UT Southwestern Medical Center (UTSW). The display of names and credentials is intended for educational purposes only and does not necessarily indicate a professional or academic relationship with UTSW. Participants are encouraged to verify the affiliations and credentials of faculty members independently if further clarification is needed.